Cross-sector initiative provides funding and support to accelerate new treatments for lung infections in CF
A partnership between ERS Genomics and Medicines Discovery Catapult will use CRISPR gene editing technology to transform the way medicines are developed
MDC maintains its high impact, nationally strategic role in the UK bioscience sector
Syndicate recognised for putting patients at the heart of its work
The investigative study will leverage MDC’s advanced microscopy capabilities
The partnership will play a vital role in supporting advances in transformative drug discovery for patient benefit
Industry partners are invited to submit expressions of interest to develop and launch the recently announced Neurodegeneration Initiative
New report says the sector must work together to de-risk funding in medicines discovery and attract more investors
One Nucleus acknowledges MDC for making an impact in the life sciences sector
MDC will steer the set-up of UK’s major national dementia initiative
See how we can help support you with your next drug discovery project.
Speak to us